Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies
Rhea-AI Summary
Inspira (Nasdaq: IINN) announced on April 13, 2026 the start of an AME technology implementation with a customer described as one of the world's 10 largest U.S.-based companies. The rollout is already underway at a U.S. R&D facility and targets cryogenic connectivity for quantum computing using Inspira's acquired AME platform.
The company says this engagement validates the AME platform, reflects ongoing commercial activity with a top-tier technology customer, and supports recurring revenue prospects and broader demand from elite technology organizations.
Positive
- Commenced AME implementation with a top-10 U.S.-based company
- Rollout underway at a U.S. research and development facility
- Strategic entry into cryogenic connectivity for quantum computing
- Company states the engagement supports recurring revenue-generating activity
Negative
- No financial terms, revenue estimates, or contract value disclosed
- No timeline or milestones provided for commercial deployment or revenue recognition
News Market Reaction – IINN
In the Apr 13 session, IINN gained 19.56%, reflecting a significant positive market reaction. Argus tracked a peak move of +22.0% during that session. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. Trading volume was elevated at 2.7x the daily average, suggesting notable buying interest.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 06 | Quantum entry via AME | Positive | -14.8% | Detailed strategy to use AME platform for quantum computing connectivity bottleneck. |
| Apr 06 | AME platform acquisition | Positive | -14.8% | Acquisition of Nano Dimension’s AME platform and related assets for up to $12.5M. |
| Mar 31 | ATM/SEPA termination | Positive | +12.5% | Termination of ATM and SEPA equity facilities to support a more disciplined capital structure. |
| Mar 26 | Full-year 2025 results | Negative | -23.1% | Low 2025 revenue, sizable operating loss and need for financing despite purchase orders. |
| Feb 25 | Nasdaq deficiency notice | Negative | -0.1% | Nasdaq notice about not meeting the $35M market value of publicly held shares requirement. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news often triggered sharp moves: acquisitions and financing/earnings updates have drawn double-digit reactions, with a mix of aligned drops on negative fundamentals and divergences where seemingly positive strategic news sold off.
Over the last few months, Inspira has balanced MedTech progress with a pivot into advanced electronics. On Apr 6, it announced acquisition of Nano Dimension’s AME platform and a quantum-computing connectivity focus, yet shares fell about 14.78%. Earlier, full-year 2025 results and a $4.75M offering on Mar 26 coincided with a -23.15% move. A Mar 31 termination of ATM and SEPA facilities saw a 12.47% rise. Today’s AME implementation update follows directly from the early-April AME acquisition and quantum strategy announcements.
Key Terms
additive manufactured electronics technical
cryogenic connectivity technical
quantum computing technical
artificial intelligence technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
RA'ANANA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today announced the commencement of an AME technology implementation with a customer that is one of the world's 10 largest U.S.-based companies. This engagement marks a significant step in the practical execution of the Company's strategic expansion into advanced technology markets following its acquisition of the AME (Additive Manufactured Electronics) business, including Inspira's entry into the cryogenic connectivity space for quantum computing, where the AME platform is being leveraged to address one of the most critical scaling bottlenecks facing the quantum industry today.
The rollout has already commenced and is focused on advancing Inspira's AME technology at a U.S. research and development facility, integrated into one of the world's most advanced corporate technology infrastructures. The customer operates at the forefront of artificial intelligence, computing infrastructure, and platform technologies globally.
The Company believes this implementation process provides high-level validation of its AME platform and reflects ongoing commercial engagement with a customer operating at the highest tier of the global corporate technology landscape. Importantly, this engagement reinforces recurring revenue-generating activity associated with that customer relationship. Furthermore, the process demonstrates broader demand from elite technology organizations for solutions addressing next-generation hardware connectivity and integration challenges.
"We view this type of engagement as confirmation of the practical relevance of our AME platform," said Dagi Ben-Noon, Chief Executive Officer of Inspira. "We are not speaking about theoretical potential. We are engaged in an active implementation process with a paying customer ranked among the largest companies in the world, a company with the resources, expertise, and infrastructure to validate our AME technology at the highest level. We view this engagement as an important signal of where this platform can go."
Inspira believes that the customer’s participation in this type of implementation process supports additional strategic opportunities and further strengthens the positioning of its AME platform across advanced technology markets.
About Inspira Technologies
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) is a technology company focused on solving the most critical physical and hardware bottlenecks in quantum computing connectivity. Inspira develops unique quantum connectivity solutions designed for high-density, thermally optimized operation in dilution cryostats, a prerequisite for scaling quantum systems beyond current physical limitations. Additionally, the Company continues to advance its medical technology portfolio, including its respiratory support and blood monitoring platforms under a dedicated business unit. For more information, please visit: www.q-trex.com and www.inspira-technologies.com
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the potential for its AME technology and business, that its AME platform is being leveraged to address one of the most critical scaling bottlenecks facing the quantum industry today, the belief that the contract implementation provides high-level validation of its AME platform, reflects ongoing commercial engagement with a customer operating at the highest tier of the global corporate technology landscape, reinforces recurring revenue-generating activity associated with that customer relationship and that it demonstrates broader demand from elite technology organizations for solutions addressing next-generation hardware connectivity and integration challenges, that it views the engagement as confirmation of the practical relevance of our AME platform and as an important signal of where its AME platform can go and its belief that the customer’s participation in this type of implementation process supports additional strategic opportunities and further strengthens the positioning of its AME platform across advanced technology markets. These forward-looking statements and their implications are based solely on the current expectations of the Company’s management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website at www.sec.gov.
Company Contact
Inspira Technologies
Email: info@inspirao2.com
Phone: +972-9-9664485
Investor Relations Contact
Arx Investor Relations
North American Equities Desk
inspira@arxhq.com
